LEISHMANIASIS
(
SEVAMED 2003)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)
January 2003
6086.
Arya SC. Enzyme-linked immunosorbent assays for diagnosis of
leishmaniasis in patients coinfected with human immunodeficiency virus. J Clin
Microbiol. 2002 Aug;40(8):3110.
6087.
Dey T, Afrin F, Anam K, Ali N. Infectivity and virulence of Leishmania
donovani promastigotes: a role for media, source, and strain of parasite. J
Eukaryot Microbiol. 2002 Jul-Aug;49(4):270-4.
6088.
Gonzalez AC, Martinez E, Carmelo E, Pinero JE, Alonso V, Del Castillo A,
Valladares B. Analysis of NLS and rRNA binding motifs in the L25 ribosomal
protein from Leishmania (viannia) braziliensis: investigation of its diagnostic
capabilities. Parasitology. 2002 Jul;125(Pt 1):51-7.
6089.
Hailu A, Kroon CC, Schoone GJ, Berhe N, Schallig HD, Kager PA. Sero-epidemiological
assessment and diagnosis of visceral leishmaniasis in an endemic locality using
Fast Agglutination Screening Test (FAST). Acta Trop. 2002 Aug;83(2):93-101.
6090.
Qadoumi M, Becker I, Donhauser N, Rollinghoff M, Bogdan C. Expression of
inducible nitric oxide synthase in skin lesions of patients with american
cutaneous leishmaniasis. Infect Immun. 2002 Aug;70(8):4638-42.
6091.
Sundar S, Sahu M, Mehta H, Gupta A, Kohli U, Rai M, Berman JD, Murray HW.
Noninvasive management of Indian visceral leishmaniasis: clinical application of
diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clin Infect
Dis. 2002 Sep 1;35(5):581-6.
Pathogenesis:
6093.
Descoteaux A, Turco SJ. Functional aspects of the Leishmania donovani
lipophosphoglycan during macrophage infection. Microbes Infect. 2002
Jul;4(9):975-81. Review.
6094.
Jappe U. Unusual skin infections in military personnel.Clin Dermatol.
2002 Jul-Aug;20(4):425-34. Review.
6095.
Junghae M, Raynes JG. Activation of p38 mitogen-activated protein kinase
attenuates Leishmania donovani infection in macrophages. Infect Immun. 2002
Sep;70(9):5026-35.
6096.
Pineda JA, Martin-Sanchez J, Macias J, Morillas F. Leishmania spp
infection in injecting drug users. Lancet. 2002 Sep 21;360(9337):950-1.
Vaccines:
6097.
Schallig HD, Oskam L. Molecular biological applications in the diagnosis
and control of leishmaniasis and parasite identification. Trop Med Int Health
2002 Aug;7(8):641-51
6098.
Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and
meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Int J Dermatol. 2002 Aug;41(8):521-4.
6099.
Gilbert IH. Inhibitors of dihydrofolate reductase in Leishmania and
trypanosomes. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):249-57. Review.
6100.
Paterson R. Miltefosine presents new hope for leishmaniasis patients.
Lancet Infect Dis. 2002 Aug;2(8):452.
6101.
Zvulunov A, Klaus S, Vardy D. Fluconazole for the treatment of cutaneous
leishmaniasis. N Engl J Med. 2002 Aug 1;347(5):370-1; discussion 370-1.
April 2003
6766.
Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra
WO,Gollob KJ, Carvalho EM.Up-regulation of Th1-type responses in mucosal
leishmaniasis patients.Infect Immun
2002 Dec;70(12):6734-40
6767.
Bosch RJ, Rodrigo AB, Sanchez P, de Galvez MV, Herrera E. Presence of
Leishmania organisms in specific and non-specific skin lesions in HIV-infected
individuals with visceral leishmaniasis. Int J Dermatol
2002 Oct;41(10):670-5
Pathogenesis:
6768.
Rodrigues EH, Felinto de Brito ME, Mendonca MG, Werkhauser RP, Coutinho
EM, Souza WV, Militao de Albuquerque Mde F, Jardim ML, Abath FG. Evaluation of
PCR for diagnosis of American cutaneous leishmaniasis in an area of endemicity
in northeastern Brazil. J Clin Microbiol
2002 Oct;40(10):3572-6
6769.
Vilela RB, Bordin JO, Chiba AK, Castelo A, Barbosa MC. RBC-associated IgG
in patients with visceral leishmaniasis (kala-azar): a prospective analysis.
Transfusion
2002 Nov;42(11):1442-7
Therapy:
6770.
Del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty
P, Gastaut JA, Costagliola D, Rosenthal E;
French Hospital Database on HIV Clinical Epidemiologic Group. Impact of
highly active antiretroviral therapy on the incidence of visceral leishmaniasis
in a French cohort of patients infected with human immunodeficiency virus. J
Infect Dis
2002 Nov 1;186(9):1366-70
6771.
Jacobs S. An oral drug for leishmaniasis. N Engl J Med
2002 Nov 28;347(22):1737-8
July 2003
7285.
Amato VS, de Andrade HF, Duarte MI. Mucosal leishmaniasis: in situ
characterization of the host inflammatory response, before and after treatment.
Acta Trop. 2003 Jan;85(1):39-49.
7286.
Haider S, Boutross-Tadross O, Radhi J, Momar N. Cutaneous ulcer in a man
returning from Central America. CMAJ. 2003 Mar 4;168(5):590-1.
7287.
Lagler H, Willheim M, Traunmuller F, Wahl K, Winkler H, Ramharter M,
Graninger W, Winkler S. Cellular profile of cytokine production in a patient
with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines
and interleukin-10. Scand J Immunol. 2003 Mar;57(3):291-5.
7288.
Veeken H, Ritmeijer K, Seaman J, Davidson R. Comparison of an rK39
dipstick rapid test with direct agglutination test and splenic aspiration for
the diagnosis of kala-azar in Sudan. Trop Med Int Health. 2003 Feb;8(2):164-7.
Pathogenesis:
7289.
Belhadj S, Pratlong F, Hammami M, Kallel K, Dedet JP, Chaker E. Human
cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus
(Northern Tunisia): epidemiological study and isoenzymatic characterization of
the parasites.Acta Trop. 2003 Jan;85(1):83-6.
Vaccines:
7290.
Ahmed S, Colmenares M, Soong L, Goldsmith-Pestana K, Munstermann L,
Molina R, McMahon-Pratt D. Intradermal infection model for pathogenesis and
vaccine studies of murine visceral leishmaniasis. Infect Immun 2003
Jan;71(1):401-10
Therapy:
7291.
Belhadj S, Pratlong F, Hammami M, Kallel K, Dedet JP, Chaker E. Human
cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus
(Northern Tunisia): epidemiological study and isoenzymatic characterization of
the parasites. Acta Trop
2003 Jan;85(1):83-6
7292.
Mehmet T, Hokelek M. Pneumonia associated with visceral leishmaniasis in
childhood. J Trop Pediatr
2003 Feb;49(1):61
7293.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar
dermal leishmaniasis.Lancet Infect Dis
2003 Feb;3(2):87-98
October 2003
8016.
Gangneux JP, Menotti J, Lorenzo F, Sarfati C, Blanche H, Bui H, Pratlong
F, Garin YJ, Derouin F. Prospective value of PCR amplification and sequencing
for diagnosis and typing of old world Leishmania infections in an area of
nonendemicity. J Clin Microbiol. 2003 Apr;41(4):1419-22.
8017.
Goswami BK, Datta S, Chakrabarti S, Chakrabarti S, Giri A, Debnath NB,
Datta K, Bandopadhayay G, Das S. Experience of visceral leishmaniasis in the
northern districts of West Bengal – the emerging sodium stibogluconate
unrespensiveness. Indian med J 2002, 96 (7), 173-6.
8018.
Haseeb AN, el-Shazly AM, Arafa MA, Morsy AT. Evaluation of
excretory/secretory Fasciola (Fhes) antigen in diagnosis of human fascioliasis.
J Egypt Soc Parasitol. 2003 Apr;33(1):123-38.
8019.
Ikonomopoulos J, Kokotas S, Gazouli M, Zavras A, Stoitsiou M, Gorgoulis
VG. Molecular
diagnosis of leishmaniosis in dogs. Comparative application of traditional
diagnostic methods and the proposed assay on clinical samples. Vet Parasitol.
2003 Apr 18;113(2):99-113.
8020.
Rahman SB, Bari AU. Laboratory profile in patients of cutaneous
leishmaniasis from various regions of Pakistan. J Coll Physicians Surg Pak. 2003
Jun;13(6):313-6.
8021.
Reithinger R, Espinoza JC, Courtenay O, Davies CR. Evaluation of PCR as a
diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic
dogs (Canis familiaris). J Clin Microbiol. 2003 Apr;41(4):1486-93.
8022.
Whittemore JC, Salman MD. Think screening unnecessary, unrealistic for
all blood donors. J Am Vet Med Assoc. 2003 Jun 1;222(11):1502; author reply
1502.
Pathogenesis:
8023.
Bertholet S, Dickensheets HL, Sheikh F, Gam AA, Donnelly RP, Kenney RT.
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in
human macrophages: a novel mechanism for intracellular parasite suppression of
activation. Infect Immun. 2003 Apr;71(4):2095-101.
8024. Cordeiro-da-Silva A, Cardoso L, Araujo N, Castro H, Tomas A, Rodrigues M, Cabral M, Vergnes B, Sereno D, Ouaissi A. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications. Immunol Lett. 2003 Apr 3;86(2):155-62.
8025.
Lang T, Courret N, Colle JH, Milon G, Antoine JC. The levels and patterns
of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with
Leishmania major by inoculation into the ear dermis depend on the infectiousness
and size of the inoculum. Infect Immun. 2003 May;71(5):2674-83.
8026.
Lima VM, Goncalves ME, Ikeda FA, Luvizotto MC, Feitosa MM. Anti-leishmania
antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz J
Med Biol Res. 2003 Apr;36(4):485-9. Epub 2003 Apr 08.
8027.
Pelletier I, Hashidate T, Urashima T, Nishi N, Nakamura T, Futai M, Arata
Y, Kasai K-, Hirashima M, Hirabayashi J, Sato S. Specific recognition of
Leishmania major poly-beta-galactosyl epitopes by galectin-9: possible
implication of galectin-9 in interaction between L. major and host cells. J Biol
Chem. 2003 Jun 20;278(25):22223-30. Epub 2003 Apr 08.
8028.
Reithinger R, Espinoza JC, Courtenay O, Davies CR. Evaluation of PCR as a
diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic
dogs (Canis familiaris). J Clin Microbiol. 2003 Apr;41(4):1486-93.
Therapy:
8029.
Carter KC, Sundar S, Spickett C, Pereira OC, Mullen AB. The in vivo
susceptibility of Leishmania donovani to sodium stibogluconate is drug specific
and can be reversed by inhibiting glutathione biosynthesis. Antimicrob Agents
Chemother. 2003 May;47(5):1529-35.
8030.
Cauchetier E, Paul M, Rivollet D, Fessi H, Astier A, Deniau M.
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the
treatment of murine visceral leishmaniasis. Ann Trop Med Parasitol. 2003
Apr;97(3):259-68.
8031.
Montero JA, Ruiz-Moreno JM, Sanchis E. Intraretinal hemorrhage associated
with leishmaniasis. Ophthalmic Surg Lasers Imaging. 2003 May-Jun;34(3):212-4.